Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2022Age and AgeingOpen Access

Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Frailty is characterised by reduced physiological reserve, but data regarding the relationship between frailty and AF are still inconsistent.

Does frailty impact clinical management and risk of adverse outcomes in patients with atrial fibrillation?

Population

10,177 AF patients enrolled in the ESC-EHRA EORP-AF General Long-Term Registry

Comparison

Frailty status assessed by a 40-item frailty index (pre-frail and frail vs robust)

Design

Registry-based cohort study

Authors

GRGiulio Francesco RomitiGeneral CardiologyMarco VitoloMarco VitoloElectrophysiologySHStephanie L. HarrisonUniversity of Liverpool

Discussion

Loading...

Member takes

Implication

Frailty assessment may aid risk stratification in AF; leaves open whether interventions targeting frailty improve outcomes.

Key Points

  • To comprehensively evaluate the prevalence, management patterns, and prognostic impact of frailty in a large European cohort of patients with atrial fibrillation.
  • Assessed 10,177 patients with atrial fibrillation enrolled in the ESC-EHRA EORP-AF General Long-Term Registry (mean age 69.0 years, 40.3% female).
  • Constructed a 40-item frailty index (FI) using the accumulation of deficits model to evaluate associations with baseline risk, management strategies, and adverse clinical outcomes.
  • Baseline categorization identified 59.6% (n=6,066) of patients as pre-frail, 21.3% (n=2,172) as frail, and only 19.1% (n=1,939) as robust.
  • Frail patients were significantly less likely to receive oral anticoagulants (OR 0.70, 95% CI 0.55–0.89) or rhythm control interventions compared to robust patients.
  • Increasing frailty was non-linearly associated with higher adverse outcome rates; oral anticoagulation reduced event risks in most patients but lost effectiveness in very high to extreme frailty.

Structured PICO

Does frailty impact clinical management and risk of adverse outcomes in patients with atrial fibrillation?

P
Population
10,177 patients with atrial fibrillation enrolled in the ESC-EHRA EORP-AF General Long-Term Registry, mean age 69.0 years, 40.3% female, in Europe.
I
Intervention
Frailty (assessed by a 40-item frailty index)
C
Comparator
Robust patients (no frailty)
O
Outcome
Association of baseline characteristics, clinical management, quality of life, healthcare resources use and risk of outcomes with frailty

Frailty is highly prevalent in European AF patients and is associated with lower OAC use and higher risk of adverse outcomes, though OAC benefit is maintained except in the extremely frail.

Cite This Study

Romiti et al. (2022) studied this question.

synapsesocial.com/papers/6a7d0f5ab0b0e582d537cd8fhttps://doi.org/10.1093/ageing/afac192

Topics

Atrial fibrillationPersistent AF managementAnticoagulation in AF
View Full Paper
Ask AI
Bookmark
Share